2seventy bio
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. 2seventy bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10% to $100,387,000. The net income raised on -$217,570,000 and profit margin reached -217%. Total operating expenses were $321,077,000.
Profit Margin
| 2018 | 54.57M | -199.74M | -365.98% |
|---|---|---|---|
| 2019 | 44.29M | -323.34M | -729.96% |
| 2020 | 248.12M | -138.17M | -55.69% |
| 2021 | 54.52M | -276.21M | -506.61% |
| 2022 | 91.49M | -254.14M | -277.77% |
| 2023 | 100.38M | -217.57M | -216.73% |
TSVT Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 100.38M | 91.49M | 54.52M | 248.12M | 44.29M | 54.57M |
Cost of revenue | 16.91M | 26.21M | 12.58M | 5.39M | 2.97M | 885K |
Gross profit | 83.46M | 65.27M | 41.93M | 242.72M | 41.31M | 53.69M |
Operating exp. | ||||||
Research and development | 230.75M | 248.73M | 261.93M | 296.46M | 297.64M | 200.49M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 321.07M | 328.18M | 355.44M | 387.36M | 379.29M | 254.12M |
Operating income | -216.70M | -262.90M | -313.50M | -144.63M | -337.97M | -203.42M |
Other income (expenses), net | -867K | 8.75M | 21.29M | 24.52M | 17.37M | 16.16M |
Income before tax | -217.57M | -254.15M | -292.21M | -120.11M | -320.59M | -199.74M |
Income tax expense | 0 | -8.98K | -15.99M | 18.05M | 2.74M | 19.16M |
Net income | -217.57M | -254.14M | -276.21M | -138.17M | -323.34M | -199.74M |
Earnings per share | ||||||
Basic EPS | -4.42 | -7.13 | -11.71 | -5.93 | -13.88 | -8.58 |
Diluted EPS | -4.42 | -7.13 | -11.71 | -5.93 | -13.88 | -8.58 |
| Data source | Data source | Data source |